Ameritas Investment Partners’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Ameritas Investment Partners’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-36,911	Closed	-$39.5K	–	3042
2022 Q4	$39.5K	Buy	36,911 +8,396	+29%	+$11.1K	﹤0.01%	2219
2022 Q3	$44K	Hold	28,515	–	–	﹤0.01%	2078
2022 Q2	$57K	Buy	28,515 +5,426	+24%	+$9.38K	﹤0.01%	1913
2022 Q1	$54K	Hold	23,089	–	–	﹤0.01%	2025
2021 Q4	$107K	Buy	23,089 +2,123	+10%	+$13.2K	﹤0.01%	1639
2021 Q3	$160K	Hold	20,966	–	–	0.01%	1379
2021 Q2	$203K	Hold	20,966	–	–	0.01%	1241
2021 Q1	$173K	Hold	20,966	–	–	0.01%	1314
2020 Q4	$143K	Buy	20,966 +2,104	+11%	+$16.9K	0.01%	1347
2020 Q3	$210K	Buy	18,862 +3,371	+22%	+$30.9K	0.01%	1009
2020 Q2	$97K	Buy	15,491 +6,016	+63%	+$23K	﹤0.01%	1437
2020 Q1	$17K	Hold	9,475	–	–	﹤0.01%	2274
2019 Q4	$32K	Hold	9,475	–	–	﹤0.01%	2165
2019 Q3	$20K	Hold	9,475	–	–	﹤0.01%	2401
2019 Q2	$25K	Buy	9,475 +2,230	+31%	+$8.03K	﹤0.01%	2330
2019 Q1	$34K	Hold	7,245	–	–	﹤0.01%	2095
2018 Q4	$17K	Hold	7,245	–	–	﹤0.01%	2446
2018 Q3	$32K	Hold	7,245	–	–	﹤0.01%	2254
2018 Q2	$52K	Buy	+7,245	New	+$49.3K	﹤0.01%	1970
2017 Q2	–	Sell	-2,189	Closed	-$9K	–	3073
2017 Q1	$9K	Buy	+2,189	New	+$11K	﹤0.01%	2740

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

OFA

Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return

LCM

Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return

STB

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

HFRG

Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

GBWM

Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return

Ameritas Investment Partners's SRNE Position: Q1 2023 in Review

Ameritas Investment Partners sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 36,911 shares — an estimated $39.5K sold.

Ameritas Investment Partners first reported a position in SRNE in Q1 2017 and held it in 20 quarters. The position peaked at $210K in Q3 2020. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

Ameritas Investment Partners reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
Ameritas Investment Partners sold 36,911 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $39.5K.
Ameritas Investment Partners first reported a position in Sorrento Therapeutics, Inc. in Q1 2017 and held it in 20 quarters.
Ameritas Investment Partners's Sorrento Therapeutics, Inc. position peaked at $210K in Q3 2020.
34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Ameritas Investment Partners's 13F filing for Q1 2023, filed 10 May 2023.